WA
REGN icon

WP Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

WP Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Sell
1,487
-79
-5% -$60.5K 0.3% 50
2025
Q4 		$1.21M Sell
1,566
-434
-22% -$295K 0.3% 49
2025
Q3 		$1.12M Sell
2,000
-96
-5% -$54.3K 0.29% 54
2025
Q2 		$1.1M Buy
2,096
+3
+0.1% +$1.67K 0.3% 51
2025
Q1 		$1.33M Sell
2,093
-138
-6% -$94.9K 0.44% 44
2024
Q4 		$1.59M Sell
2,231
-102
-4% -$85.6K 0.53% 36
2024
Q3 		$2.45M Sell
2,333
-278
-11% -$309K 0.9% 28
2024
Q2 		$2.74M Sell
2,611
-165
-6% -$160K 0.88% 25
2024
Q1 		$2.67M Sell
2,776
-40
-1% -$38K 0.88% 25
2023
Q4 		$2.47M Sell
2,816
-25
-0.9% -$20.6K 0.92% 24
2023
Q3 		$2.34M Sell
2,841
-20
-0.7% -$15.7K 0.97% 24
2023
Q2 		$2.06M Sell
2,861
-92
-3% -$70.9K 0.82% 27
2023
Q1 		$2.43M Hold
2,953
– – 1% 23
2022
Q4 		$2.13M Sell
2,953
-53
-2% -$39.1K 0.95% 27
2022
Q3 		$2.07M Hold
3,006
– – 0.94% 25
2022
Q2 		$1.78M Sell
3,006
-49
-2% -$31.9K 0.77% 30
2022
Q1 		$2.13M Sell
3,055
-110
-3% -$69.6K 0.88% 26
2021
Q4 		$2M Hold
3,165
– – 0.83% 29
2021
Q3 		$1.92M Sell
3,165
-30
-0.9% -$18.6K 0.79% 26
2021
Q2 		$1.78M Buy
3,195
+181
+6% +$91.7K 0.74% 26
2021
Q1 		$1.43M Buy
+3,014
New +$1.47M 0.62% 32

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

WP Advisors's REGN Position: Q1 2026 in Review

WP Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 5% in Q1 2026, selling an estimated $60.5K and leaving 1,487 shares worth $1.15M. The position accounts for 0.3% of the portfolio, ranked #50.

WP Advisors first reported a position in REGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.74M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • WP Advisors held 1,487 shares of Regeneron Pharmaceuticals worth $1.15M as of Q1 2026.
  • WP Advisors sold 79 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $60.5K.
  • Regeneron Pharmaceuticals made up 0.3% of WP Advisors's portfolio in Q1 2026, its #50 holding.
  • WP Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • WP Advisors's Regeneron Pharmaceuticals position peaked at $2.74M in Q2 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on WP Advisors's 13F filing for Q1 2026, filed 4 May 2026.